New research from experts at the University of Virginia (UVA) says that GLP-1 drugs may help people lose weight, but do not ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

In Wyoming, 33% of adults struggle with obesity, and Rabon has seen GLP-1 drugs become a popular starting point to lead to ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...

A study finds that adjunctive use of GLP-1 receptor agonists before and after undergoing bariatric surgery produces greater ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

In addition to the psychological and social impacts, GLP-1 drugs may also influence hormonal balance. Studies show that ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...